Objective: The use of antipsychotics to treat the behavioral symptoms of dementia is associated
with greater mortality. The authors examined the mortality risk of individual agents to …

Objective: Mortality rates in the year following new antipsychotic medication starts for
neuropsychiatric symptoms of dementia were compared with rates after starts of other psychiatric …

Background The influenza A (H1N1) 2009 monovalent vaccination programme was the largest
mass vaccination initiative in recent US history. Commensurate with the size and scope …

Context Use of atypical antipsychotics for neuropsychiatric symptoms of dementia increased
markedly in the 1990s. Concerns about their use began to emerge in 2002, and in 2005, the …

Background: Information about the effectiveness of oral antivirals in preventing short- and
long-term COVID-19–related outcomes in the setting of Omicron variant transmission and …

Background: In the last decade, there has been heightened awareness that pain management
needs to be a priority for all health care settings and clinicians. The article will overview …

Federal health agency leaders describe plans to develop infrastructure for generating high-quality
evidence to improve care. They argue that it will be necessary to embed research in …

Remifentanil is an esterase-metabolized opioid developed for use in anesthesia. The
principal metabolite of remifentanil, GR90291, is considered to be less potent. This study …

Background . Although gatifloxacin is no longer available, other fluoroquinolones may
significantly interfere with glucose homeostasis. The objective of the present study was to …

Importance Implementation of pharmacogenetic testing to guide drug prescribing has potential
to improve drug response and prevent adverse events. Robust data exist for more than …